Insulin sensitivity in patients with primary aldosteronism: a follow-up study.
BACKGROUND
The relationship between aldosterone and glucose metabolism is poorly understood, and there is substantial disparity among findings of studies that have examined glucose tolerance and insulin sensitivity in patients with primary aldosteronism.


OBJECTIVE
The objective of the study was to determine the outcome of glucose tolerance and insulin sensitivity in patients with primary aldosteronism after treatment.


METHODS
This was a prospective study of patients who received a diagnosis of primary aldosteronism and were followed up for an average period of 5.7 yr (range, 3-9 yr).


METHODS
The study was conducted at a university referral center.


METHODS
A consecutive sample of 47 patients with tumoral or idiopathic aldosteronism was followed up after either surgical or medical treatment. Patients with primary aldosteronism were compared with 247 patients with essential hypertension with the same severity and duration of disease and 102 normotensive subjects.


METHODS
Short- and long-term changes in glucose tolerance and insulin sensitivity were measured.


RESULTS
After adjustment for age, gender, and body mass index, patients with primary aldosteronism had greater homeostasis model assessment index (P < 0.05) and plasma insulin response to an oral glucose load (P < 0.05) and lower quantitative insulin sensitivity check index (P < 0.01) than normotensive controls. Changes in insulin sensitivity were significantly greater in essential hypertension than primary aldosteronism, and this difference was confirmed by assessment with the hyperinsulinemic-euglycemic clamp (P < 0.01). Treatment of primary aldosteronism decreased blood pressure significantly, and during the initial 6 months of follow-up, parameters of insulin sensitivity were restored to normal. Analysis of subsequent follow-up showed nonsignificant changes in glucose metabolism parameters in both adrenalectomized and spironolactone-treated patients.


CONCLUSIONS
Insulin resistance is present in patients with tumoral and idiopathic aldosteronism, but the defect appears less severe than in patients with essential hypertension. Treatment with surgery or aldosterone antagonists restores rapidly and persistently normal sensitivity to insulin.
Catena
Cristiana
C
Clinica Medica, University of Udine, Piazzale S. Maria della Misericordia, 1, 33100 Udine, Italy.
Lapenna
Roberta
R
Baroselli
Sara
S
Nadalini
Elisa
E
Colussi
Gianluca
G
Novello
Marileda
M
Favret
Grazia
G
Melis
Alessandra
A
Cavarape
Alessandro
A
Sechi
Leonardo A
LA
D000450:Aldosterone / Q000097:blood; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D002097:C-Reactive Protein / Q000378:metabolism; D005260:Female; D005947:Glucose / Q000378:metabolism*; D005951:Glucose Tolerance Test; D006801:Humans; D006929:Hyperaldosteronism / Q000378:metabolism* / Q000628:therapy; D006973:Hypertension / Q000378:metabolism* / Q000628:therapy; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D007558:Italy; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D011446:Prospective Studies; D012083:Renin / Q000097:blood
D000959:Antihypertensive Agents; D001786:Blood Glucose; D007328:Insulin; D000450:Aldosterone; D002097:C-Reactive Protein; D012083:Renin; D005947:Glucose; D011188:Potassium